Intellia Therapeutics Ownership | Who Owns Intellia Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Intellia Therapeutics Ownership Summary

Intellia Therapeutics is owned by 94.27% institutional investors, 1.21% insiders, and 4.52% retail investors. Ark investment management is the largest institutional shareholder, holding 12.14% of NTLA shares. ARK Innovation ETF is the top mutual fund, with 8.54% of its assets in Intellia Therapeutics shares.

NTLA Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Intellia Therapeutics	94.27%	1.21%	4.52%
Sector	Healthcare Stocks	47.06%	8.01%	44.93%
Industry	Biotech Stocks	44.97%	7.82%	47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ark investment management	11.60M	12.14%	$259.51M
Blackrock	9.60M	10.05%	$214.79M
Vanguard group	9.10M	9.53%	$203.66M
Deep track capital, lp	4.80M	5.03%	$107.42M
State street	4.36M	4.57%	$97.64M
Nikko asset management americas	3.26M	3.41%	$72.91M
Sumitomo mitsui trust	3.26M	3.41%	$72.91M
Morgan stanley	2.34M	2.45%	$52.32M
Federated hermes	2.30M	2.41%	$51.49M
Geode capital management	2.29M	2.40%	$51.35M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Discovery value fund	561.56K	6.39%	$12.57M
Deep track capital, lp	4.80M	3.21%	$107.42M
Contrarius investment management	1.92M	2.68%	$42.87M
Ark investment management	11.60M	2.30%	$259.51M
Himension capital (singapore) pte.	1.03M	1.63%	$23.05M
Bioimpact capital	443.50K	1.54%	$9.93M
Orchard capital management	170.01K	1.15%	$3.80M
Nikko asset management americas	3.26M	0.84%	$72.91M
Evolutionary tree capital management	36.26K	0.84%	$811.54K
Lewis asset management	46.53K	0.80%	$1.04M

Top Buyers

Holder	Shares	% Assets	Change
Ark investment management	11.60M	2.30%	606.51K
Deep track capital, lp	4.80M	3.21%	589.22K
Contrarius investment management	1.92M	2.68%	564.88K
Blackrock	9.60M	0.00%	488.34K
Nuveen asset management	865.63K	0.01%	481.76K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	781.77K	0.00%	-3.38M
Rokos capital management llp	-	-	-1.14M
Price t rowe associates inc /md/	1.24M	0.00%	-380.09K
Voloridge investment management	452.45K	0.04%	-343.07K
Marshall wace, llp	-	-	-335.41K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	240.41K	0.00%	240.41K	$5.38M
Mirae asset global etfs	234.81K	0.01%	234.81K	$5.26M
Sphera funds management	139.42K	0.43%	139.42K	$3.12M
Engineers gate manager lp	61.53K	0.03%	61.53K	$1.38M
Corebridge financial	51.83K	0.01%	51.83K	$1.16M

Sold Out

Holder	Change
Dinuzzo private wealth	-1.00
Baldwin brothers llc/ma	-4.00
Family firm	-15.00
Nelson, van denburg & campbell wealth management group	-17.00
Innealta capital	-18.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	302	0.67%	90,028,919	-0.69%	94	1.05%	160	5.26%	86	-2.27%
Mar 31, 2024	300	-2.28%	90,656,601	6.41%	94	1.03%	152	-11.11%	88	10.00%
Dec 31, 2023	307	4.07%	85,199,452	6.57%	95	1.18%	171	14.77%	80	19.40%
Sep 30, 2023	295	-1.67%	79,946,745	2.21%	90	1.15%	149	7.97%	67	-11.84%
Jun 30, 2023	300	-0.33%	78,214,958	-0.57%	88	1.10%	138	-3.50%	76	-16.48%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
ARK Innovation ETF	8.67M	8.54%	-
ARK Disruptive Innovation Full Composite	8.28M	8.15%	159.07K
ARK Genomic Revolution ETF	3.15M	3.10%	15.16K
Vanguard Total Stock Mkt Idx Inv	3.14M	3.09%	-29.14K
ARK Genomic Revolution	3.08M	3.03%	517.81K
SPDR® S&P Biotech ETF	2.82M	2.77%	31.18K
iShares Russell 2000 ETF	2.47M	2.43%	-5.56K
Vanguard Small Cap Index	2.42M	2.37%	4.75K
Nikko AM ARK Disruptive Innovation A USD	2.08M	2.04%	-34.91K
Contrarius Global Equity Institutional	1.87M	1.84%	121.42K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 02, 2024	Dube Michael P	VP, Chief Accounting Officer	Sell	$38.25K
Jul 01, 2024	Clark Eliana	EVP, Chief Technical Officer	Sell	$9.29K
Jun 17, 2024	Verwiel Frank	-	Sell	$37.63K
Mar 04, 2024	BASTA JAMES	EVP, General Counsel	Sell	$75.78K
Mar 04, 2024	Clark Eliana	EVP, Chief Technical Officer	Sell	$19.96K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q3	-	1
2024 Q2	-	1
2024 Q1	-	12
2023 Q4	-	1

NTLA Ownership FAQ

Who Owns Intellia Therapeutics?

Intellia Therapeutics shareholders are primarily institutional investors at 94.27%, followed by 1.21% insiders and 4.52% retail investors. The average institutional ownership in Intellia Therapeutics's industry, Biotech Stocks , is 44.97%, which Intellia Therapeutics exceeds.

Who owns the most shares of Intellia Therapeutics?

Intellia Therapeutics’s largest shareholders are Ark investment management (11.6M shares, 12.14%), Blackrock (9.6M shares, 10.05%), and Vanguard group (9.1M shares, 9.53%). Together, they hold 31.72% of Intellia Therapeutics’s total shares outstanding.

Does Blackrock own Intellia Therapeutics?

Yes, BlackRock owns 10.05% of Intellia Therapeutics, totaling 9.6M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 214.79M$. In the last quarter, BlackRock increased its holdings by 488.34K shares, a 5.36% change.

Who is Intellia Therapeutics’s biggest shareholder by percentage of total assets invested?

Discovery value fund is Intellia Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.39% of its assets in 561.56K Intellia Therapeutics shares, valued at 12.57M$.

Who is the top mutual fund holder of Intellia Therapeutics shares?

ARK Innovation ETF is the top mutual fund holder of Intellia Therapeutics shares, with 8.54% of its total shares outstanding invested in 8.67M Intellia Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools